Rezolute, Inc. (NASDAQ:RZLT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 12, 2026.
The Healthcare company reported Q0 revenue of .
Rezolute, Inc.'s stock currently trades at $3.63 with a market capitalization of $129.4M.


